222 related articles for article (PubMed ID: 32820337)
1. Intestinal microbiota changes in Graves' disease: a prospective clinical study.
Yan HX; An WC; Chen F; An B; Pan Y; Jin J; Xia XP; Cui ZJ; Jiang L; Zhou SJ; Jin HX; Ou XH; Huang W; Hong TP; Lyu ZH
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32820337
[TBL] [Abstract][Full Text] [Related]
2. Molecular Alteration Analysis of Human Gut Microbial Composition in Graves' disease Patients.
Ishaq HM; Mohammad IS; Shahzad M; Ma C; Raza MA; Wu X; Guo H; Shi P; Xu J
Int J Biol Sci; 2018; 14(11):1558-1570. PubMed ID: 30263008
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota May Play a Significant Role in the Pathogenesis of Graves' Disease.
Jiang W; Yu X; Kosik RO; Song Y; Qiao T; Tong J; Liu S; Fan S; Luo Q; Chai L; Lv Z; Li D
Thyroid; 2021 May; 31(5):810-820. PubMed ID: 33234057
[No Abstract] [Full Text] [Related]
4. Comparative assessment of gut microbial composition and function in patients with Graves' disease and Graves' orbitopathy.
Shi TT; Xin Z; Hua L; Wang H; Zhao RX; Yang YL; Xie RR; Liu HY; Yang JK
J Endocrinol Invest; 2021 Feb; 44(2):297-310. PubMed ID: 32449092
[TBL] [Abstract][Full Text] [Related]
5. Gut Dysbiosis Contributes to the Imbalance of Treg and Th17 Cells in Graves' Disease Patients by Propionic Acid.
Su X; Yin X; Liu Y; Yan X; Zhang S; Wang X; Lin Z; Zhou X; Gao J; Wang Z; Zhang Q
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785703
[TBL] [Abstract][Full Text] [Related]
6. Associations between gut microbiota and thyroidal function status in Chinese patients with Graves' disease.
Chen J; Wang W; Guo Z; Huang S; Lei H; Zang P; Lu B; Shao J; Gu P
J Endocrinol Invest; 2021 Sep; 44(9):1913-1926. PubMed ID: 33481211
[TBL] [Abstract][Full Text] [Related]
7. Preliminary Observation of the Changes in the Intestinal Flora of Patients With Graves' Disease Before and After Methimazole Treatment.
Yang M; Zheng X; Wu Y; Zhang R; Yang Q; Yu Z; Liu J; Zha B; Gong Q; Yang B; Sun B; Zeng M
Front Cell Infect Microbiol; 2022; 12():794711. PubMed ID: 35402292
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study.
Shi TT; Xin Z; Hua L; Zhao RX; Yang YL; Wang H; Zhang S; Liu W; Xie RR
J Endocrinol Invest; 2019 Aug; 42(8):967-978. PubMed ID: 30674011
[TBL] [Abstract][Full Text] [Related]
9. Alterations of Gut Microbiota in Patients With Graves' Disease.
Chang SC; Lin SF; Chen ST; Chang PY; Yeh YM; Lo FS; Lu JJ
Front Cell Infect Microbiol; 2021; 11():663131. PubMed ID: 34026662
[TBL] [Abstract][Full Text] [Related]
10. Alteration of the Intestinal Microbial Flora and the Serum IL-17 Level in Patients with Graves' Disease Complicated with Vitamin D Deficiency.
Yang M; Li F; Zhang R; Wu Y; Yang Q; Wang F; Yu Z; Liu J; Cha B; Gong Q; Yang B; Sun B; Ding H
Int Arch Allergy Immunol; 2022; 183(2):225-234. PubMed ID: 34544076
[TBL] [Abstract][Full Text] [Related]
11. The Potential Role of Pyrroloquinoline Quinone to Regulate Thyroid Function and Gut Microbiota Composition of Graves' Disease in Mice.
Liu X; Jiang W; Lu G; Qiao T; Gao D; Zhang M; Cai H; Chai L; Yi W; Lv Z
Pol J Microbiol; 2023 Dec; 72(4):443-460. PubMed ID: 38095308
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of disease.
Masetti G; Moshkelgosha S; Köhling HL; Covelli D; Banga JP; Berchner-Pfannschmidt U; Horstmann M; Diaz-Cano S; Goertz GE; Plummer S; Eckstein A; Ludgate M; Biscarini F; Marchesi JR;
Microbiome; 2018 May; 6(1):97. PubMed ID: 29801507
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiome in the Graves' disease: Comparison before and after anti-thyroid drug treatment.
Jeong C; Baek H; Bae J; Hwang N; Ha J; Cho YS; Lim DJ
PLoS One; 2024; 19(5):e0300678. PubMed ID: 38820506
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study.
Diana T; Brown RS; Bossowski A; Segni M; Niedziela M; König J; Bossowska A; Ziora K; Hale A; Smith J; Pitz S; Kanitz M; Kahaly GJ
J Clin Endocrinol Metab; 2014 May; 99(5):1648-55. PubMed ID: 24517152
[TBL] [Abstract][Full Text] [Related]
15. The microbiota and autoimmunity: Their role in thyroid autoimmune diseases.
Köhling HL; Plummer SF; Marchesi JR; Davidge KS; Ludgate M
Clin Immunol; 2017 Oct; 183():63-74. PubMed ID: 28689782
[TBL] [Abstract][Full Text] [Related]
16. Alteration of the intestinal flora may participate in the development of Graves' disease: a study conducted among the Han population in southwest China.
Yang M; Sun B; Li J; Yang B; Xu J; Zhou X; Yu J; Zhang X; Zhang Q; Zhou S; Sun X
Endocr Connect; 2019 Jul; 8(7):822-828. PubMed ID: 31137015
[TBL] [Abstract][Full Text] [Related]
17. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
18. Gut dysbiosis is associated with primary hypothyroidism with interaction on gut-thyroid axis.
Su X; Zhao Y; Li Y; Ma S; Wang Z
Clin Sci (Lond); 2020 Jun; 134(12):1521-1535. PubMed ID: 32519746
[TBL] [Abstract][Full Text] [Related]
19. Relationship between intestinal microbial dysbiosis and primary liver cancer.
Zhang L; Wu YN; Chen T; Ren CH; Li X; Liu GX
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):149-157. PubMed ID: 30661942
[TBL] [Abstract][Full Text] [Related]
20. Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy.
Marinò M; Rotondo Dottore G; Ionni I; Lanzolla G; Sabini E; Ricci D; Sframeli A; Mazzi B; Menconi F; Latrofa F; Vitti P; Marcocci C; Chiovato L
J Endocrinol Invest; 2019 Apr; 42(4):471-480. PubMed ID: 30132285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
